These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30210010)

  • 101. The topical administration of rhEGF-loaded nanostructured lipid carriers (rhEGF-NLC) improves healing in a porcine full-thickness excisional wound model.
    Gainza G; Bonafonte DC; Moreno B; Aguirre JJ; Gutierrez FB; Villullas S; Pedraz JL; Igartua M; Hernandez RM
    J Control Release; 2015 Jan; 197():41-7. PubMed ID: 25449803
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.
    Shamma RN; Aburahma MH
    Int J Nanomedicine; 2014; 9():5449-60. PubMed ID: 25473283
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Ubidecarenone-Loaded Nanostructured Lipid Carrier (UB-NLC): Percutaneous Penetration and Protective Effects Against Hydrogen Peroxide-Induced Oxidative Stress on HaCaT Cells.
    Wang J; Wang H; Xia Q
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29941831
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies.
    Ricci M; Puglia C; Bonina F; Di Giovanni C; Giovagnoli S; Rossi C
    J Pharm Sci; 2005 May; 94(5):1149-59. PubMed ID: 15793804
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
    Khurana S; Jain NK; Bedi PM
    Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.
    Shrivastava N; Khan S; Baboota S; Ali J
    Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
    Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Topical delivery of Bruton's tyrosine kinase inhibitor and curcumin-loaded nanostructured lipid carrier gel: Repurposing strategy for the psoriasis management.
    Jain H; Devabattula G; Bhat A; Dalvi H; Rangaraj N; Godugu C; Srivastava S
    Pharm Dev Technol; 2022 Nov; 27(9):975-988. PubMed ID: 36330998
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats.
    Amer RI; Yassin GE; Mohamed RA; Fayez AM
    AAPS PharmSciTech; 2021 Jul; 22(5):204. PubMed ID: 34258696
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Nano-Sized Technologies for Miconazole Skin Delivery.
    Firooz A; Namdar R; Nafisi S; Maibach HI
    Curr Pharm Biotechnol; 2016; 17(6):524-31. PubMed ID: 26927217
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Effect of the Surfactant and Liquid Lipid Type in the Physico-chemical Characteristics of Beeswax-based Nanostructured Lipid Carrier (NLC) of Metformin.
    Qushawy M
    Pharm Nanotechnol; 2021; 9(3):200-209. PubMed ID: 33618652
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Development of terbinafine solid lipid nanoparticles as a topical delivery system.
    Chen YC; Liu DZ; Liu JJ; Chang TW; Ho HO; Sheu MT
    Int J Nanomedicine; 2012; 7():4409-18. PubMed ID: 22923986
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Lipid Nanoparticles for Enhancing the Physicochemical Stability and Topical Skin Delivery of Orobol.
    Kim MH; Jeon YE; Kang S; Lee JY; Lee KW; Kim KT; Kim DD
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32899309
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections.
    Baghel S; Nair VS; Pirani A; Sravani AB; Bhemisetty B; Ananthamurthy K; Aranjani JM; Lewis SA
    Dermatol Ther; 2020 Nov; 33(6):e13959. PubMed ID: 32618400
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia.
    Uprit S; Kumar Sahu R; Roy A; Pare A
    Saudi Pharm J; 2013 Oct; 21(4):379-85. PubMed ID: 24227958
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies.
    Bolla PK; Meraz CA; Rodriguez VA; Deaguero I; Singh M; Yellepeddi VK; Renukuntla J
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470517
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Enhancing the Oral Bioavailability of Candesartan Cilexetil Loaded Nanostructured Lipid Carriers: In Vitro Characterization and Absorption in Rats after Oral Administration.
    Anwar W; Dawaba HM; Afouna MI; Samy AM; Rashed MH; Abdelaziz AE
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33142816
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design.
    Andalib S; Varshosaz J; Hassanzadeh F; Sadeghi H
    Adv Biomed Res; 2012; 1():45. PubMed ID: 23326776
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib.
    Joshi M; Patravale V
    Drug Dev Ind Pharm; 2006 Sep; 32(8):911-8. PubMed ID: 16954103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.